baber/WOPTO huggingface dataset:
Patent FI-924576-A0 (FI)
Inventor: POMATO NICHOLAS
IPC: C12P21/08
Filed: 1992-10-09
Abstract: The present invention comprises the epitope recognized by the human monoclonal antibody 28A32, the human tumor antigen containing this epitope, which we have identified, isolated and characterized, and human MCA 28A32. The invention also relates to the use of antibodies to the antigen containing this epitope for diagnosis and monitoring of treatment of cancer and to the use of this antigen in the preparation of vaccines to elicit an immune response similar to that obtained against tumor cells containing this epitope.
Patent FI-931274-A0 (FI)
Inventor: BUCHHOLZ RAINER
IPC: B01D61/16
Filed: 1993-03-23
Abstract: Process for preparing purified glycolipids by membrane separation processes. Glycolipids may be purified and concentrated using a membrane separation process at acid pH and employing a membrane with a cut-off size of 30,000.
Patent FI-944734-A0 (FI)
Inventor: ZAMBONI ROBERT
IPC: C07D215/12
Filed: 1994-10-07
Abstract: Compounds having the formula I: <CHEM> are leukotriene antagonists and inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.
Patent FI-950205-A0 (FI)
Inventor: SCHARF MICHAEL
IPC: F16C33/74
Filed: 1995-01-18
Abstract: The invention relates to a sleeve bearing provided with lip seals, which are each integrated into front areas of the sleeve bearing particularly for use in rough mixed friction operation. The lip seals each consist of a holding part, a support part and a pretensioned sealing lip, which rests linearly on an associated shaft/axis in the built-in state. The holding part force-lockingly engages into an annular groove. A cavity, which is formed between the shaft/axis and the holding part or rather the support part can be filled with a lubricant.
Patent FI-952592-A0 (FI)
Inventor: WALLANDER CARL OTTO
IPC: C02F11/12
Filed: 1995-05-29
Abstract: A device for dewatering and/or transport of liquid-containing screening or sludge material. The device includes a chamber (10) which is being under a reduced pressure and which is formed by the walls (11-13), with an inlet (14) and with means (24, 25) for continuously compression and separation of liquid from the screening material/the sludge. Which means act toward an outlet opening (15, 31), for evacuation of incoming material without equalization of air pressure. The inlet (14) includes a pipeline (17) with a valve (18) which can be opened and closed for recurrent intake of a quantity of screening material in the pipeline and for a direct or gradual transport of said quantity along the pipeline (17) and into the chamber (10), under preservation of a varying pressure in the chamber (10).
Patent FI-953823-A0 (FI)
Inventor: KOPPELMANS JOHANNES FRANCISCUS
IPC: G11C8/04
Filed: 1995-08-11
Abstract: By providing a digital video memory arrangement with first and second address generating means, digital video signals can be written at a first location of a non-mechanical memory and (almost) immediately read out from a second location of the non-mechanical memory, with the reading out both being capable of featuring backward and forward jumps. As a consequence of a coupling between the first and the second address generating means it becomes impossible to, on the one hand, unjustly pass with jumping in the read signal the running or stopped write signal and, on the other hand, unjustly pass with the running read signal the stopped write signal. To this end the second address generating means dispose over determining means for determining, in response to at least the write signal and the read signal, a permitted address jump. <MATH>
Patent FI-962155-A0 (FI)
Inventor: VANDENBERK JAN
IPC: A61P25/18
Filed: 1996-05-22
Abstract: PCT No. PCT/EP94/03804 Sec. 371 Date May 3, 1996 Sec. 102(e) Date May 3, 1996 PCT Filed Nov. 16, 1994 PCT Pub. No. WO95/14691 PCT Pub. Date Jun. 1, 1995The present invention is concerned with novel compounds having the formula    <IMAGE>  (I)  the pharmaceutically acceptable acid addition salts thereof and the stereochemically isomeric forms thereof, wherein Alk represents C1-4alkanediyl; D is a bicyclic heterocycle of formula    <IMAGE>  (a)  orC2-6alkenyl; C2-6alkynyl; C3-6cycloalkyl optionally substituted with C1-4alkyl; C1-19alkyl optionally substituted with C3-6cycloalkyl, halo, C1-6alkyloxy or cyano; and each R2 independently is hydrogen or C1-4alkyl. Novel compounds; compositions; processes for preparing novel compounds and intermediates are described.
Patent FI-963276-A0 (FI)
Inventor: SAGVIK RAGNAR HARALD
IPC: B31F5/00
Filed: 1996-08-22
Abstract: PCT No. PCT/IB95/00113 Sec. 371 Date May 12, 1997 Sec. 102(e) Date May 12, 1997 PCT Filed Feb. 21, 1995 PCT Pub. No. WO95/23061 PCT Pub. Date Aug. 31, 1995A skiving method comprises forming by milling, along an edge zone of a packaging blank comprised of a liquid-absorbent layer and at least two liquid-barrier layers thereon, a tongue, a recess inwardly of the tongue, a land inwardly of the recess, and a groove inwardly of the land, folding over the edge zone to insert the tongue into the groove, and sealing the edge zone to the remainder of the sheet material, preferably by mechanical pressure alone.\!
Patent IL-66690-A0 (IL)
Title: Oven for carrying out gas reactions
IPC: B01J19/00
Filed: 1982-09-01
Abstract: There is described a furnace for the performance of gas reactions in a ceramic assembly of tubes in which the heating chambers (2), the recuperators (4) and the flue gas-branch channel (5) are arranged in a compact, energy saving type of construction. The furnace is especially suited for the production of hydrocyanic acid according to the BMA process (hydrocyanic acid-methane-ammonia process).
Patent IL-76331-A0 (IL)
Title: Acylated saccharin derivatives,their preparation and their use as pesticides
IPC: A61K31/425
Filed: 1985-09-09
Abstract: Fungicidally and bactericidally active novel acylated saccharins of the formula   <IMAGE>   in which X is oxygen or sulphur and R is -CO-R1 or -SO2-OR2, R1 is alkyl, halogenalkyl, alkoxy, halogenoalkoxy or alkylthio, or is optionally substituted aryl, aryloxy or arylthio, cycloalkoxy or -NR3R4, R2 is alkyl or phenyl, R3 is alkyl, and R4 is alkyl, phenyl, halogenoalkylthio, alkoxycarbonyl or phenoxycarbonyl, or -NR3R4 is a saccharin radical.
Patent IL-79835-A0 (IL)
Title: P-acylaminobenzamides
IPC: A61K31/165
Filed: 1986-08-25
Abstract: This invention provides certain 4-acylamino benzamide derivatives, their pharmaceutical formulations, and their use as anticonvulsant agents.
Patent IL-85950-A0 (IL)
Title: Apparatus for wet cleaning a floor or wall surface
IPC: A47L11/292
Filed: 1988-03-31
Abstract: An apparatus for wet cleaning floor or wall surfaces comprises one or more cylindrical brushes (12) which may be rotated by a motor (13) so that they are throwing liquid and dirt from the floor or wall surface on to a rotating cylinder (15) or a moving endless belt. Liquid and dirt is continuously removed from the outer peripheral surface of the cylinder or belt by means of a suction nozzle (19) extending along the axial length of the cylinder and immediately adjacent to the peripheral surface thereof. The suction nozzle (19) may have a lower edge functioning as a scraping member (40) which is in contact with the peripheral surface of a cylinder (15). Liquid and dirt removed from the cylinder (15) by means of the suction nozzle (19) is passed to a container for collecting dirty liquid.
Patent IL-88494-A0 (IL)
Title: Preparation of a supported metallocene-alumoxane catalyst for gas phase polymerization
IPC: C08F4/642
Filed: 1988-11-25
Abstract: This invention relates to a process for preparing a supported metallocene alumoxane catalyst for use in the gas phase polymerization of olefins. The invention particularly relates to the use of silica gel containing from about 6 to about 10 percent by weight adsorbed water as the catalyst support material. It has been found that such silica gel may be safely added to an aluminum trialkyl solution to form by direct reaction with the adsorbed water content of the silica gel catalyst support material the alumoxane component of the catalyst system. An alumoxane coated silica gel is formed to which a metallocene may be added and the resulting material dried to free flowing powder. The dry free flowing powder may then be used as a supported metallocene alumoxane catalyst complex for gas phase polymerization of olefins.
Patent IL-95451-A0 (IL)
Title: Omega-phenylamino alkanoic acids substituted on the aromatic nucleus by a radical derived from 19-nor steroids,their salts,preparation process,and pharmaceutical compositions containing them
IPC: C07J1/00
Filed: 1990-08-21
Abstract: New products (I): 
<IMAGE>
 in which R1 denotes an aliphatic hydrocarbon radical (C1-8), Ra and Rb denote a hydrogen or an alkyl (C1-4), R2 denotes a hydrogen or an optionally substituted alkyl (C1-12), n denotes one of the values from 1 to 6, Z denotes a carboxyl group which is free or converted into salt in the form of an alkali metal or alkaline-earth metal, ammonium or amine salt, X denotes the residue of an optionally substituted pentagonal or hexagonal ring optionally carrying an unsaturation, and the wavy line in position 13 means that R1 may be in an alpha or beta position, their salts, process for their preparation and their application as medications.
Patent IL-98444-A0 (IL)
Title: Pharmaceutical composition for treating addiction to habit-forming drugs containing certain 4-(bis(halophenyl)methylene)-1-piperidinyl derivatives
IPC: A61K31/505
Filed: 1991-06-11
Abstract: Agents for treating addiction to habit-forming drugs and symptoms related to withdrawal of said drugs which agents are 4-[bis(halophenyl)methylene]-1-piperidinyl derivatives of formula <CHEM> or a pharmaceutically acceptable acid addition salt thereof, wherein A represents -CH=CH- or -S-.
Patent IL-98935-A0 (IL)
Title: Liposomal immunogenic carriers
IPC: A61K31/685
Filed: 1991-07-23
Abstract: The antibody response to a target antigen may be enhanced by incorporating the antigen into a liposome along with an additional constituent which contains at least one T-helper lymphocyte recognition site. The liposomes can include a wide variety of lipid materials. Both the antigen and the T-helper lymphocite recognition site containing constituent may be associated with the liposome by using hydrophobic interactions or by covalent attachment to a lipid.
Patent IL-99064-A0 (IL)
Title: Substituted pyrroles,their preparation and pharmaceutical compositions containing them
IPC: C07D471/10
Filed: 1991-08-02
Abstract: Compounds of the formula <CHEM> wherein R<1> and R<3> together form a bond and R<2> represents hydrogen or R<1> and R<2> together form a bond and R<3> represents hydrogen; R<4>, R<5>, R<6> and R<7> each independently represent hydrogen, halogen, alkyl, haloalkyl, alkoxy, nitro, amino, alkanoylamino, aroylamino, alkylthio or alkylsulphonyl; R<8> represents hydrogen, alkyl or aralkyl; X represents -N(R<9>)- or -CHN(R<1><0>,R<1><1>)- in which R<9>, R<1><0> and R<1><1> each represent hydrogen, alkyl, aralkyl or alkanoyl; m stands for 0-2 and n stands for 1-3, with the proviso that the sum of m and n is 1-3; p stands fo 0-4 and q stands for 0-4, with the proviso that the sum of p and q is 2-4 when X represents -N(R<9>)-, that the sum of p and q is 1-5 when X represents -CHN(R<1><0>,R<1><1>)- and R<1> and R<2> together form a bond, that the sum of p and q is 0-4 when X represents -CHN(R<1><0>,R<1><1>)- and R<1> and R<3> together form a bond and that p stands for 1-4 when X represents -N(R<9>)-, R<1> and R<3> together represent a bond and m stands for 0, as well as pharmaceutically acceptable salts of acidic compounds of formula I with bases and of basic compounds of formula I with acids, are useful in the control or prevention of inflammatory, immunological, oncological, bronchopulmonary, dermatological or cardiovascular disorders or for the treatment of asthma, AIDS or diabetic complications or for the stimulation of hair growth. They can be prepared from correspondingly substituted furandiones.
Patent AU-PO856097-A0 (AU)
Title: Vector
IPC: C12N15/09
Filed: 1997-08-14
Abstract: This invention relates to a recombinant vector including a recombinant porcine adenovirus, stably incorporating and capable of expression of at least one heterologous nucleotide sequence. The nucleotide sequence is preferably one which encodes an antigenic determinant of Hog Cholera Virus or Pseudorabies virus. The further invention relates to a method of production of recombinant vectors, to methods of preparation of vaccines based on the vectors, to administration strategies and to methods of protecting pigs from disease.
Patent FI-20011078-A0 (FI)
Inventor: MINKKINEN LASSI
IPC: D21F9/00
Filed: 2001-05-23
Abstract: The invention relates to an arrangement for controlling the edge of pulp mass in a web former, the web former comprising a space formed by two wires or the like, into which space the pulp mass is fed. The wires or the like are supported on a chamber units, which each time include at least one chamber for receiving the water removed from the pulp mass. In conjunction with the side edge of the said web former are arranged pulp mass edge control means, which include an edge sealing part. The edge sealing part extends, in the lateral direction of the web former, by a distance between the chamber units in such a way that it will prevent the pulp mass edge from passing and/or spreading in the lateral direction of the web former into the area of the said edge of the web former. The invention also relates to a method for controlling the pulp mass edge in a web former.
Patent FI-20041473-A0 (FI)
Inventor: AULANKO ESKO
IPC: B66B/
Filed: 2004-11-16
Abstract: An elevator roping arrangement includes: hoisting ropes; diverting pulleys; and a fixing and support arrangement. First and fourth diverting pulleys are disposed on the elevator car, while second and third diverting pulleys are disposed in an upper part of an elevator shaft. The hoisting ropes pass from a traction sheave to the diverting pulleys. The fixing and support arrangement is disposed at a top end of elevator car guide rails and includes two support beams. Each support beam is fixed at a first end to a wall of the shaft, extends from the first end to a second end away from the wall, and is fixed to a guide rail between the ends. A vertical plane is defined between the guide rails. At least one of the diverting pulleys is on an opposite side of the plane from the wall, and is disposed at a distance from the plane.
Patent IL-107983-A0 (IL)
Title: Polygonal sheet material packing means especially for bottles and the like and machine for preparing such packing means
IPC: B65D5/462
Filed: 1993-12-10
Abstract: - Package (E1) in cardboard or corrugated cardboard, in the form of a basket, for packaging loads such as rows of bottles (BO). - According to the invention, the cover of the said package is formed from two trough pieces (1A, 12.1, 20.1 and 3A, 12.3 and 20.3) with a trapezoidal cross section, which are upturned and nested, permitting accurate production of the said cover regardless of the nature and/or the shape of the load. Provision is also made for a machine making it possible to continuously close the said packages during their progression towards their discharge. <IMAGE>
Patent IL-108685-A0 (IL)
Title: Oxytocin antagonist
Inventor: FLOURET GEORGE
IPC: A61K38/095
Filed: 1994-02-17
Abstract: A novel compound is disclosed for inhibiting the effects of oxytocin in a female mammal. As an analog of oxytocin the compound is named [(S)PMP1,D-Trp2,Pen6,Arg8] oxytocin. This compound can be administered to pregnant women to arrest premature labor while avoiding unwanted side effects due to antagonism of the antidiuretic hormone, vasopressin.
Patent IL-112507-A0 (IL)
Title: Modified rhinoviral peptide
IPC: C12N15/09
Filed: 1995-02-01
Abstract: The present invention relates to systems which make it possible to introduce mutations in the VP1/2A and in the complete coding region of the 2A protease, to test systems with which the "cis" and "trans" activity can be investigated, to oligonucleotides which encode the mutations, and to the oligopeptides derived therefrom and to the use thereof, furthermore oligopeptides which are cleaved by the 2A protease into trans with different efficiency, and to the use thereof.
Patent IL-141127-A0 (IL)
Title: Cell lines for propagation of mutated herpes viruses
IPC: C12N7/04
Filed: 1999-08-03
Abstract: A process for propagating a mutant herpes virus having a mutation in its endogenous HSV VP16 gene or a homologue thereof, which process comprises infecting a cell line with the mutant herpes virus and culturing the cell line, wherein the cell line comprises a nucleic acid sequence encoding a functional herpes simplex virus (HSV) VP16 polypeptide, or a homologue thereof, operably linked to a control sequence permitting expression of the polypeptide in said cell line; the nucleic acid sequence being (i) capable of complementing the endogenous gene and (ii) unable to undergo homologous recombination with the endogenous gene. In addition, the present invention provides cell lines which can be used for the growth of mutant herpes viruses which have defects in certain immediate early genes together with mutations in VP16 or homologue thereof.
Patent IL-142916-A0 (IL)
Title: Magnetic resonance tomography contrast agent
IPC: A61K49/06
Filed: 1999-12-03
Abstract: The invention relates to an MRT (magnetic resonance tomography) contrast agent with a viscosity of 500 to 2,500 cP, comprising a suspension of kaolin, optionally combined with bentonite in a citrate buffer, and to a method for producing MRT contrast agents of this type.
Patent IL-148084-A0 (IL)
Title: Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
IPC: C07D495/04
Filed: 2000-08-12
Abstract: This invention is directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans that inhibit Factor Xa, pharmaceutical compositions comprising these compounds and their use for inhibiting Factor Xa or treating pathological conditions in a patient that may be ameliorated by administration of such compounds. This invention is also is also directed to substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans which directly inhibit both Factor Xa and Factor IIa (thrombin), to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds and to a method of simultaneously directly inhibiting both Factor Xa and Factor IIa (thrombin).
Patent IL-148343-A0 (IL)
Title: Injectable buprenorphine microparticle compositions and their use
IPC: A61P25/30
Filed: 2000-08-25
Abstract: An injectable slow-release methadone, partial opioid agonist or opioid antagonist formulation is provided comprising methadone, a partial opioid agonist or opioid antagonist in a poly(D,L-lactide) excipient with a small amount of residual ethyl acetate. Upon intramuscular or subcutaneous injection of the composition, methadone, a partial opioid agonist or opioid antagonist is released in a controlled manner over an extended period of time. The composition finds use in the treatment of heroin addicts and alcoholics to reduce consumption of the abused substances. Of particular interest are the drugs buprenorphine, methadone and naltrexone.
Patent IL-154339-A0 (IL)
Title: A loading mechanism for a modular commercial printer
IPC: B65H5/02
Filed: 2000-09-13
Abstract: A print media loading mechanism (150) for a printer (10) includes a feeding device comprising a pair of surface-defining elements (152) which define surfaces which are movable relative to each other in the same direction parallel to a direction of feed of the print media (46), the feeding device being operable to engage a leading edge of the print media (46) for feeding it towards an exit region (86) of the printer to effect loading of the printer. A displacement arrangement (160) displaces the surface-defining elements, in a direction transverse to a direction of feed of the print media, into abutment with each other when loading of the print media is required and for displacing the surface-defining elements (152) out of abutment with each other when loading of the print media has been completed. The surface defining elements may be perforated or foraminous belts to allow drying air to pass there through.
Patent IL-172531-A0 (IL)
Title: Tablet comprising fluvastatin and carmellose calcium
IPC: A61K9/20
Filed: 2005-12-12
Abstract: The present invention relates to a fluvastatin-containing tablet, particularly a fluvastatin-containing tablet which has excellent disintegrating property and good bioavailability.
Patent IL-178282-A0 (IL)
Title: Method and apparatus for maximizing the use of available capacity in a communication system
IPC: H04B7/005
Filed: 2006-09-25
Abstract: A method and apparatus for maximizing the use of available capacity in a communication system having a base station and a plurality of mobile stations. The forward link includes a plurality of traffic streams sent on at least one channel from the base station to the mobile stations. The forward link is subject to a maximum power ceiling. A first output power level associated with simultaneously transmitting a first set of one or more traffic streams on the forward link is initially determined. Next, the first output power level is compared to the maximum power ceiling; and at least one time frame in the forward link having available capacity for transmitting a portion of at least one further traffic stream is identified. The first set of traffic streams and the portion of the at least one further traffic stream are then transmitted simultaneously during the at least one frame on the forward link.
Patent IL-185100-A0 (IL)
Title: Disposable assembly containing a skin pieercing element
IPC: A61B5/15
Filed: 2007-08-07
Abstract: The invention relates to devices used in the fields of drag delivery or sampling. More particularly, it relates to a disposable assembly which is fitted to an actuator device which causes the skin piercing element to enter the skin to deliver a drug (or other substance) or take a sample. Preferably the assembly is “made safe” after actuation, such that the disposable assembly can't be reused and more preferably still the skin piercing element is safely housed in the assembly such that it does not constitute a “sharps” risk.
Patent IL-189340-A0 (IL)
Title: Method for verifying a target device connected to a master device
IPC: H04N7/16
Filed: 2008-02-07
Abstract: A verification table (L1) containing a certificate identifier list is transmitted by broadcast to a target device. The certificate identifier list is stored in a master device. The verification of a certificate of a target device by the master device is performed when verification activation is included in an extracted verification indication associated with the content received by the master device from a diffusion center. The stored list is used to authorize or prohibit the exchange of data with the target device.
Patent IL-220133-A0 (IL)
Title: Nucleic acid molecules and recombinant vaccines comprising sequences encoding immunogens and immunomodulators, compositions comprising said nucleic acid molecules, and uses of said nucleic acid molecules, recombinant vaccines, compositions and immunogens and immunomodulators in the preparation of medicaments and as medicaments
IPC: C12N15/09
Filed: 2012-06-03
Abstract: Improved vaccines which include a nucleotide sequence that encodes immunomodulating protein operably linked to regulatory elements are disclosed. The improved vaccines include DNA vaccines, recombinant vaccines for delivering foreign antigen and live attenuated vaccines. Methods of immunizing individuals are disclosed. Compositions for and methods of treating individuals with autoimmune diseases are disclosed.